LEADER 03285nam 22003733 450 001 9910880294203321 005 20240609090313.0 010 $a1-4988-4541-X 035 $a(MiAaPQ)EBC31459835 035 $a(Au-PeEL)EBL31459835 035 $a(CKB)32245876200041 035 $a(EXLCZ)9932245876200041 100 $a20240609d2024 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aEbola 205 $a2024th ed. 210 1$aLos Angeles :$cGideon Informatics, Incorporated,$d2024. 210 4$d©2024. 215 $a1 online resource (91 pages) 327 $aIntro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Ebola -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Bioterrorism -- References -- Andorra -- Australia -- References -- Bangladesh -- References -- Benin -- References -- Brunei -- Cameroon -- References -- Central African Republic -- References -- China -- References -- Congo -- References -- Cuba -- References -- The Democratic Republic of Congo -- References -- Egypt -- References -- Ethiopia -- References -- France -- References -- Gabon -- References -- Germany -- References -- Ghana -- References -- Guinea -- References -- Indonesia -- References -- Italy -- References -- Ivory Coast -- References -- Japan -- Kenya -- References -- Lebanon -- Liberia -- References -- Madagascar -- References -- Mali -- References -- Mexico -- Mozambique -- References -- The Netherlands -- References -- Nigeria -- References -- Norway -- References -- The Philippines -- References -- The Russian Federation -- References -- Scotland -- References -- Senegal -- References -- Sierra Leone -- References -- Singapore -- South Africa -- South Sudan -- References -- Spain -- References -- Sudan -- References -- Switzerland -- References -- Taiwan -- Tanzania -- References -- Thailand -- References -- Uganda -- References -- The United Kingdom -- References -- The United States -- References -- Zambia -- References -- Zimbabwe -- References -- Vaccines & -- Immunoglobulins -- Ebola immune globulin -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster. 327 $aToxic Effects for Ebola immune globulin (10 listed) -- Contraindications for Ebola immune globulin (0 listed) -- Trade names of Ebola immune globulin (8 listed) -- Ebola - viral vector vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Ebola - viral vector vaccine (8 listed) -- Contraindications for Ebola - viral vector vaccine (3 listed) -- Trade names of Ebola - viral vector vaccine (6 listed) -- About GIDEON. 700 $aBerger$b Stephen$01210032 701 $aGIDEON science team$b Gideon science$01765422 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910880294203321 996 $aEbola$94207327 997 $aUNINA LEADER 00425oas 2200181z- 450 001 9910891266003321 005 20160622170557.0 035 $a(CKB)1000000000043118 035 $a(EXLCZ)991000000000043118 100 $a20121018cuuuuuuuu -u- - 101 0 $aeng 200 $aKompakt 210 $aMalmö$cMoKS 311 $a1404-0093 906 $aJOURNAL 912 $a9910891266003321 996 $aKompakt$94260413 997 $aUNINA